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Abstract 25 
Objectives 26 
Persistent (PD, defined as diarrhoea lasting ≥14 days) and prolonged diarrhoea (ProD, defined as diarrhoea 27 
lasting 7-13 days) are assumed to be closely linked to acute malnutrition. Improved treatment relies on better 28 
characterization of these diarrhoeal syndromes. Our objective was to assess the prevalence of prolonged and 29 
persistent diarrhoea, to estimate their co-occurrence with acute malnutrition and association with demographic 30 
and clinical factors.  31 
 32 
Methods 33 
We conducted a case-control study where cases were children under 5 years of age with diarrhoea and controls 34 
were children without diarrhoea, frequency matched weekly by age and district of residency. Controls for cases 35 
0-11 months were recruited from vaccination rooms and controls for cases 12-59 months were recruited by 36 
house visits using random locations in the catchment area of the study sites. Data were analysed by mixed 37 
model logistic regression. 38 
 39 
Results 40 
We enrolled 1134 cases and 946 controls. Among the cases, 967 (85%) had acute diarrhoea (AD), 129 (11%) 41 
had ProD and 36 (3.2%) had PD. Cases more often had acute malnutrition at enrolment (17% vs 4%, p<0.0001) 42 
and were born prematurely (5.7% vs 1.8%, p<0.0001) compared with controls. Seventy-five percent of ProPD 43 
cases did not have acute malnutrition. Cases with AD and ProPD had different symptomatology, even beyond 44 
illness duration.  45 
 46 
Conclusions 47 
ProPD is common among children presenting with diarrhoea and is not confined to children with acute 48 
malnutrition. There is an urgent need for studies assessing causes of ProPD with and without acute malnutrition 49 
to develop treatment guidelines for these conditions.  50 
Introduction 51 
Most guidelines and studies on childhood diarrhoea in low- and middle-income countries focus on causes and 52 
management of acute diarrhoea (AD), defined as diarrhoea lasting <7 days (1). There is limited knowledge of 53 
causes that lead to progression to persistent diarrhoea (PD), defined as diarrhoea lasting ≥14 days, despite its 54 
major contribution to diarrhoeal deaths (2). Prolonged diarrhoea (ProD), defined as diarrhoea lasting 7-13 days, 55 
has attracted interest as it substantially increases the risk of PD (3). ProD accounts for around 10% and PD for 56 
approximately 5% of all diarrhoea cases but estimates vary greatly (3-5).  57 
Researchers agree that there is a close link between malnutrition and extended duration of diarrhoea (3, 6) and 58 
while limited data is available, it has previously been suggested that prevention and treatment of malnutrition 59 
might reduce the incidence of PD (7). Diarrhoea of longer duration is common in children with severe acute 60 
malnutrition (SAM) (8), but the prevalence among children with moderate acute malnutrition (MAM) is 61 
unknown. Moreover, there are few reports on the proportion of MAM and SAM among patients with prolonged 62 
or persistent diarrhoea (ProPD), i.e. diarrhoea lasting at least 7 days. 63 
While there are clinical management guidelines available for children with SAM, there are not yet any 64 
international treatment recommendations for MAM and only a technical note with suggestions (9, 10). It is not 65 
clear how best to manage children who also have ProPD, or how best to treat ProPD in children who do not 66 
have MAM or SAM. The recommended treatment for PD includes a specific nutritional regimen, which is 67 
quite complex and has not been implemented widely (11, 12). Although some studies reported a positive effect 68 
of nutritional interventions (13-15), there are no specific recommendations for the treatment of ProD (1, 12, 69 
16). 70 
Under the assumption that nutritional status is one of the key host prognostic factors in diarrhoea, a better 71 
understanding of the distinction between ProPD, MAM and SAM is needed for evidence-based treatment 72 
algorithms tailored to each of these partially overlapping and vulnerable groups. Previous studies have 73 
identified risk factors for PD (17-19) and ProD (3, 20), however most of these studies were conducted over 74 
two decades ago before the current definition of acute malnutrition and did not include MAM or distinguish 75 
between MAM and SAM.  76 
The objective of this study was to estimate the proportion of ProPD among children with diarrhoea and to 77 
estimate how many of them had acute malnutrition. We compared cases with diarrhoea with non-diarrhoea 78 
controls and we furthermore aimed to describe factors associated with ProPD with a primary focus on acute 79 
malnutrition, by comparing children with ProPD with children with AD.   80 
Methods 81 
Study design and participants 82 
The study was a case-control study in South Eastern Ethiopia. Cases were children under 5 years of age with 83 
diarrhoea of any duration, seen at Jimma University Specialized Teaching Hospital (JUSTH) or Serbo Health 84 
Centre (SHC). Children residing outside the 15 districts defining Jimma Town and its catchment area or the 8 85 
districts defining the SHC catchment area were excluded. JUSTH is a tertiary referral hospital and SHC covers 86 
a neighbouring area approximately 16 km away. Children with diarrhoea were enrolled whether or not 87 
diarrhoea was the primary complaint leading them to seek health care. Exclusion criteria were enrolment as a 88 
case within the last 60 days and admission as an inpatient for longer than 24 hours prior to enrolment. Cases 89 
were enrolled from February 2017 till July 2018, from morning till evening seven days a week at JUSTH and 90 
during working hours on weekdays at SHC.  91 
Controls without diarrhoea in the previous 48 hours were found by frequency matching by geography of 92 
household, age group and time. Age groups were 0-5 months, 6-11 months, 12-23 months, and 24-59 months. 93 
In JUSTH controls were recruited from any of the 15 districts defined as JUSTH catchment area and in SHC 94 
from a random sample of the districts that cases had been enrolled from during the preceding week. Controls 95 
in the age groups 0-5 and 6-11 months were recruited from vaccination rooms at the two sites. A control was 96 
eligible if the child came from one of the 15 districts in JUSTH catchment area, or from one of randomly 97 
selected districts in the SHC catchment area based on that week’s control plan. If it was not possible to enrol 98 
the control in the 0-5 or 6-11-month age categories from the vaccination room within one week after frequency 99 
matching, they were recruited from the community instead, in the following week. The controls for the 12-59 100 
months old patients were recruited in the community. We identified eligible community controls by randomly 101 
selecting a GPS point in the JUSTH catchment area or in the randomly selected district in the SHC catchment 102 
area, by using QGIS v2.18 (21) and district borders from ArcGIS (22). The GPS point was plotted on Google 103 
Earth (23) and selected if there was a road within 300 meters of the point accessible by a motorbike (defined 104 
as any visible path minimum 2 m wide). The study nurse travelled to the GPS location, or as close as possible 105 
based on the road conditions, then stopped, and faced in a pre-specified random compass direction. The house 106 
nearest to this direct line, in walking distance, was selected. If no child of the required age lived in the first 107 
house, or if the caregiver refused, the steps above were repeated, but this time with that house as the starting 108 
point. If an eligible child resided in the house, but could not be found in two attempts, the procedure was 109 
repeated. If the listed control had not been enrolled within two weeks after frequency matching, that control 110 
was dropped, except in a few circumstances where controls had to be enrolled in the third week, because of 111 
unexpected disruptions of study activities.  112 
Initially, the case-control ratio was 10:6 (6 controls for 10 cases), but from July 2017 it was changed to 1:1 113 
due to more cases coming from outside the catchment areas and due to a lower caseload than expected. To 114 
determine factors associated with diarrhoea we compared cases and controls; to determine factors associated 115 
with longer duration of diarrhoea, we compared cases with ProPD with cases with AD. 116 
Data collection 117 
Demographic and clinical data were collected using standardized case report forms. Before returning home, 118 
information on treatment and clinical status was collected by the study nurse or from the hospital medical 119 
records. If diarrhoea had lasted for less than 14 days at the time of enrolment, the study nurses contacted the 120 
caregivers by phone 14 days after the onset of diarrhoea to assess progression to ProD or PD. Follow-up visit 121 
to the paediatric outpatient’s department was encouraged for all additional ProD and PD cases identified this 122 
way. All cases were offered HIV testing; first-line testing was conducted with the First Response™ HIV 1-2-123 
O Card test (Premier Medical Corporation Ltd, Daman, India); for children younger than 18 months, positive 124 
test results were confirmed by PCR and for children older than 18 months, positive results were confirmed by 125 
a second HIV test kit, Uni-Gold™ HIV (Trinity Biotech Manufacturing Ltd, Co. Wicklow, Ireland). HIV 126 
counselling and testing was done by routine clinical staff or study nurses trained in HIV counselling and 127 
testing. Information to caregivers and HIV treatment to children were offered according to routine care.  128 
Definitions 129 
Diarrhoea was defined as the passage of three or more watery or loose stools within the preceding 24 hours; 130 
the presence and duration of diarrhoea was assessed by caregiver recall. Diarrhoea that had lasted 14 days or 131 
longer was defined as PD, diarrhoea of 7-13 days’ duration as ProD and diarrhoea lasting <7 days as AD. 132 
Dysentery was defined as at least one loose stool per day with visible blood in the previous 24 hours. SAM 133 
was defined as one or more of the following: weight-for-height z-score (WHZ) ≤-3 of the WHO standard 134 
curves (24), and/or mid-upper arm circumference (MUAC) ≤115 mm and/or presence of bilateral oedema 135 
involving at least the feet. MAM was defined as a WHZ ≤-2 and >-3 or a MUAC ≤125 mm and > 115 mm 136 
with no oedema. For children below 6 months, only WHZ ≤-2 and presence of bilateral oedema was used to 137 
define SAM and MAM. HIV status was either based on HIV testing on enrolment or by previous testing as 138 
reported by the caregiver. Children below 18 months with an HIV positive mother was considered HIV 139 
exposed and uninfected if a PCR result for the child was negative or not available. Stunting was defined as a 140 
length/height-for-age z-score ≤-2 of the WHO standard curves (24). A child had moderate to severe diarrhoea 141 
if they had diarrhoea together with very sunken eyes, an abdominal skin pinch as assessed by the research 142 
nurse to go back slowly (abnormal but ≤2 s) or very slowly (>2 s), had dysentery, received IV fluids or was 143 
admitted for any reason (25). Fever was defined as an axillary temperature ≥37.5°C. Access to “improved 144 
water” was defined as having the main source of drinking water for the household as either a private tap in the 145 
house, public tap, rainwater collected in a container, or borehole/protected spring. A Water/sanitation, Assets 146 
and Maternal education (WAM) index was calculated similarly as in the MAL-ED study; access to “improved” 147 
or “unimproved” water and/or sanitation, the presence or absence of eight household assets and maternal 148 
education (26). Rotavirus vaccine in Ethiopia is an oral vaccine (Rotarix TM) that is given twice, usually at 6 149 
weeks and 10 or 14 weeks of age. We defined the child as vaccinated against rotavirus if two doses had been 150 
received at least four weeks apart.  151 
Statistical methods 152 
Double data entry was done with EpiData 3.1 (EpiData, Odense, Denmark) and data analysis with SAS 153 
Enterprise Guide, Version 7.11 of the SAS System for Windows (SAS Institute Inc., Cary, NC, USA). A p 154 
value lower than 0.05 was considered to represent statistical significance and 95% confidence intervals were 155 
used to represent statistical precision. We used an unconditional mixed model logistic regression, adjusted for 156 
age and with random effects for district of residency and enrolment month, for binary outcomes. In case of 157 
problems with convergence the district of residency variable was excluded. We used these models for both the 158 
comparison between cases and controls, and for comparisons between different groups of cases. Since two 159 
different methods were used to enrol controls, we assessed each variable for interaction with age group (0-11 160 
months versus 12-59 months) and presented stratified analyses in case of a significant interaction.  161 
Because the infancy controls were recruited from vaccination rooms, we did not include analysis of rotavirus 162 
vaccination in the comparison between cases and controls. Furthermore, since length and height were not 163 
measured among controls in the community, we excluded the analysis of WHZ and stunting in the comparison 164 
between cases and controls.  165 
Ethical issues 166 
Jimma University IRB (Reference: RPGC/610/2016), the Ethiopian National Research Ethics Review 167 
Committee (Reference: JU JURPGD/839/2017) and the Regional Committee for Medical and Health Research 168 
Ethics of Western Norway (Reference: 2016/1096) approved the study. Children were eligible after obtaining 169 
written informed consent from the caregivers (thumbprint signature for caregivers who could not read or write).  170 
  171 
Results  172 
Of 1413 cases screened, 1156 (82%) were eligible, and of these 1134 (98%) were enrolled in the study (figure 173 
1). The main reasons for ineligibility was residency outside catchment area (n=161), refusal (n=48) and 174 
enrolment as a case during the last 60 days (n=33). Using weekly case enrollment lists, and after the frequency 175 
matching procedure had been completed, we had weekly target lists that in total comprised 979 controls. Of 176 
these, 20 controls were not enrolled, since a suitable control had not been successfully enrolled within the 177 
enrollment window because of unexpected staff shortages or disruption of study activities. Of the 959 178 
remaining controls 946 (99%) were enrolled (figure 1). Of the enrolled controls, 935 (99%) were enrolled 179 
within two weeks and the remaining 11 in week three. Of all the enrolled children, 11 controls and 21 cases 180 
had previously been enrolled as either a case >60 days earlier or as a control. Three hundred and thirty-eight 181 
(30%) the cases were enrolled before the change in case-control ratio from 10:6 to 1:1. Only two cases (0.2%) 182 
were HIV exposed. 183 
On enrolment, 967 (85%) of the cases had AD, 129 (11%) had ProD and 36 (3.2%) had PD. Eighty-seven 184 
cases (8%) had dysentery. Eleven cases (1%) were admitted and five (0.4%) died, of whom one had ProD and 185 
four AD.  186 
We found that 25% of cases with ProPD had MAM or SAM, and that acute malnutrition was more frequently 187 
present among cases with ProPD than with AD (OR 1.85, 95%CI 1.23, 2.79) (figure 2). Yet, of the 164 cases 188 
with ProPD (anthropometric data not available for one case), 123 (75%) did not have any form of acute 189 
malnutrition (figure 2). 190 
Factors associated with any diarrhoea 191 
In the adjusted analysis we found that MUAC ≤125 mm (OR 4.58, 95%CI 2.64, 7.97), being born prematurely 192 
(OR 2.22, 95%CI 1.27, 4.28), or having visited a health facility in the previous month (OR 1.43, 95%CI 1.14, 193 
1.79) was associated with having diarrhoea (table 1). A low WAM index was negatively correlated with 194 
diarrhoea (OR 0.80, 95%CI 0.66, 0.98). Taking re-enrolment into account had negligible effect on the 195 
estimates. HIV status/exposure was not included in the model due to low prevalence. Interactions with age 196 
group (age < 12 vs ≥ 12 months), defined as heterogeneity of ORs were found for the following variables; 197 
MUAC (3.07 (1.91, 4.95) vs 5.31 (2.36, 11.95)), exclusive breastfeeding <6 months (1.32 (0.96, 1.82) vs 0.84 198 
(0.66, 1.08)), born prematurely (1.47 (0.70, 3.08) vs 7.03 (2.73, 16.10)) and WAM index (1.15 (0.88, 1.51) vs 199 
0.45 (0.34, 0.58)). 200 
AD compared with ProPD 201 
Among diarrhoea cases we found in the adjusted analysis that MUAC≤125 mm (OR 2.10, 95%CI 1.05, 4.22) 202 
and stunting (OR 1.99, 95%CI 1.16, 4.22) were associated with ProPD (table 2). Treatment with zinc also 203 
correlated with ProPD (OR 3.49, 95% CI 1.71, 7.12). Lastly, we found a trend that fever upon enrolment (OR 204 
0.45, 95%CI 0.20, 1.04) and history of vomiting (OR 0.63, 95%CI 0.39, 1.02) correlated with AD. Taking re-205 
enrolment into account made little difference to these estimates. 206 
To determine whether the estimates of the characterises comparing AD and ProPD cases were related to 207 
differences in nutritional status, we performed an additional analysis where we adjusted for wasting and 208 
stunting only. This had limited effect on the estimates in the comparison between AD and ProPD (data not 209 
shown). We also compared ProPD cases with acute malnutrition and ProPD cases without acute malnutrition 210 
and we did not find any clinically relevant difference in the estimates of the demographic and clinical 211 
characteristics listed in table 2 (data not shown). 212 
A follow-up interview 14 days after onset of the diarrhoeal episodes was successfully completed (96% of these 213 
interviews were conducted by phone) in 329 (34%) of the children that presented with AD and 53 (41%) of 214 
the cases that presented with ProD. Due to the low phone follow-up and differences between responders and 215 
non-responders, the results are not presented. 216 
Discussion 217 
ProPD comprised 14% of the diarrhoea cases, – this is in line with previous studies (3, 4). Since ProPD 218 
contributes disproportionately to the total number of diarrhoeal days in a population (27) and a large proportion 219 
of diarrhoeal deaths is assumed to be caused by PD (2), more attention needs to be given to these conditions.  220 
We found that 25% of cases with ProPD had acute malnutrition. Interestingly, the proportions with acute 221 
malnutrition among ProD and PD cases seemed similar and higher than what was observed among the AD 222 
cases. This could indicate that grouping ProD and PD together as ProPD may be clinically relevant. The 223 
observed proportion of cases with acute malnutrition is similar to the conclusions from a previous study in 224 
Bangladesh (28) but comparison with results from older publications is challenging since many of these studies 225 
either used definitions of malnutrition that are now outdated or they did not include acute malnutrition, - in 226 
particular MAM (17). While we found that a higher proportion of cases with ProPD were acutely malnourished 227 
compared with AD, a key observation in our study is that three quarters of the children with ProPD did not 228 
have acute malnutrition. Other factors may be equally, or more, important for ProPD, including perturbation 229 
of the normal gut microbiota (11), environmental enteric dysfunction (27), micronutrient deficiencies (29), or 230 
differences in the relative aetiological contribution of various enteropathogens (27). 231 
There is a clear need for more clinical and epidemiological studies on ProPD and a major unanswered question 232 
is how to best treat children with ProPD in the absence of acute malnutrition (table 3); our results suggest that 233 
the majority of ProPD patients fall into this category and are therefore currently left without specific treatment 234 
guidelines or with complex recommendations. The guideline for PD cases without malnutrition recommends 235 
a complex nutritional treatment regimen that few countries have implemented (12, 30). Furthermore, ProD 236 
cases are currently treated as AD cases as no specific recommendations exist and the evidence base is 237 
particularly weak in the absence of malnutrition. Whether the current nutritional therapy recommended for 238 
MAM and SAM is clinically effective in patients with ProPD should be evaluated in well-designed trials (31). 239 
Such trials could form the basis of an update of current guidelines for treatment of diarrhoea in children with 240 
acute malnutrition.  241 
We found that both acute malnutrition and stunting was more common in children with ProPD than with AD. 242 
This does not, however, imply a causal relationship of malnutrition being caused by diarrhoea and could even 243 
be explained by ProPD being caused by malnutrition. Our finding of higher average WAM index in cases than 244 
in non-diarrhoea controls could be explained by cases representing the segment of the population that can 245 
afford to seek health care. 246 
Children with AD tended to have a history of vomiting. This has to our knowledge not been described 247 
previously. A recent multi-country study found that infections with rotavirus, Shigella, adenovirus and 248 
Cryptosporidium were positively associated with fever, vomiting and high stool frequency whereas infections 249 
with Campylobacter spp. were negatively associated with these signs and symptoms (32). The difference in 250 
signs and symptoms between AD and ProPD in our study supports the possibility that the spectrum of 251 
enteropathogens that cause AD and ProPD might be different. While it is well-known that the spectrum is 252 
overlapping yet different between AD and PD (27), less in known about ProPD combined. Recent studies that 253 
used multitarget quantitative PCR assays were able to attribute almost 90% of AD episodes, at a population 254 
level, to specific pathogens (33). This contrasts with the sparse knowledge on the aetiology of ProD and PD 255 
(27). Further studies could use similar methods to estimate the proportion of ProPD that can be attributed to 256 
specific enteropathogens. Substantial differences in aetiological spectrum could be used to develop 257 
interventions against specific pathogens including point-of-care diagnostic testing. Fever on enrolment was 258 
correlated with AD and likely explained by these cases being in an earlier stage of their disease, when fever is 259 
more common.  260 
Treatment with zinc was associated with ProPD, a possible explanation is that longer duration of illness 261 
increased the likelihood of having received treatment in a health facility before enrolment (34) and that children 262 
with AD were treated with zinc in the community and therefore not presenting at our facilities.  263 
Besides the association between malnutrition and diarrhoeal duration, previous studies found that use of 264 
antibiotics for diarrhoea (18), lack of breastfeeding (17), and young age (19) was associated with PD. The 265 
latter two were associated with ProD in a few studies (3, 20). The relative importance of these putative risk 266 
factors for ProPD should be established in new studies, as there has been a shift in childhood malnutrition, 267 
antibiotic use, treatment of acute malnutrition, and access to health care in recent years (35). We attempted to 268 
conduct a phone follow-up among cases to determine how many progressed to ProPD, however with limited 269 
success. A recent study in Kenya reported a higher follow-up success rate and reported ProD and PD rates of 270 
35% and 7% of the diarrhoea cases, respectively (5). We suggest that future diarrhoea studies should include 271 
follow-up; (36); cell phone follow-up warrants further exploration in particular, as it could be developed into 272 
a simple and cost-effective tool to reach more children with ProPD. 273 
Our study has several limitations. The study was designed to inform clinical care and was therefore conducted 274 
in a health-care setting. Data on putative risk factors for diarrhoea was collected retrospectively by interview. 275 
Inherent to the retrospective case-control study design is that we cannot reliably make assumptions about the 276 
causal direction between factors assessed at enrolment, e.g. malnutrition and diarrhoea. Both health workers 277 
and caregivers knew whether the child was a case or a control, which might have affected both the clinical 278 
assessments and the caregiver’s responses. To limit recall and other information and recall bias, we used a 279 
standard case report form for cases and controls that mainly consisted of choosing between predefined answers. 280 
Even more importantly, the interviewers were rigorously trained in how to elicit answers independent of 281 
whether the child was well or ill. 282 
Conclusion 283 
ProPD is common among children presenting with diarrhoea and is not restricted to children with acute 284 
malnutrition. Further studies evaluating the cause of and treatment for ProPD are highly needed.  285 
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Figure 1: Flow diagram 409 
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1413 cases screened 
1156 eligible cases identified 
- Work overload: 22 
959 eligible controls identified 
- Controls missed: 20 
1134 cases enrolled 946 controls enrolled 
- Resided outside catchment area: 161 
- No information on residency: 2 
- Inpatients for longer than 24 hours: 10 
- Enrolled during the last 60 days: 33 
- Refused: 48 
- Caregiver younger than 18 years: 2 
- Other: 1 
 
 
 
979 controls screened 
- Diarrhoea in the previous 48 hours: 13 
  
Figure 2: Proportion of children with acute malnutrition by duration of diarrhoea 
 
** Twenty-two controls and seven cases had missing anthropometric data 
* Proportion of children with MAM or SAM among children with any form of diarrhoea differed significantly from 
controls (p<0.0001). Proportion of children with MAM or SAM among children with prolonged diarrhoea differed 
significantly from cases with acute diarrhoea (p=0.006) 
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Table 1: Associations between demographic/clinical characteristics and diarrhoea based on 1134 cases and 946 controls given as ORs with 
95% confidence intervals (95%CI)  
 Non-diarrhoea 
controls 
Cases Adjusted OR1 
(95% CI) 
Number of children 946 1134  
Female sex, n (%) 439 (47%) 491 (43%) 0.86 (0.71, 1.05) 
Age, months, mean (sd) 17.8 (±12.6) 16.6 (±11.7) 0.99 (0.99, 1.00) 
Mid-upper arm circumference ≤125 mm for >6 
months, n (%) 
18 (2%) 104 (10%) 4.58 (2.64, 7.97) 
Exclusive breastfeeding for <6 months, n (%)  332 (38%) 413 (39%) 1.06 (0.86, 1.30) 
Born prematurely, n (%) 17 (1.8%) 64 (5.7%) 2.33 (1.27, 4.28) 
WAM2 index < 0.50, n (%) 523 (57%) 538 (49%) 0.80 (0.66, 0.98) 
Antibiotic use in previous week, n (%) 70 (7.5%) 116 (10.6%) 1.25 (0.86, 1.80) 
Health facility visit in previous month, n (%) 238 (25%) 406 (36%) 1.43 (1.14, 1.79) 
Admission to health facility, n (%) 78 (8.3%) 107 (9.5%) 1.05 (0.74, 1.50) 
Previous treatment for malnutrition, n (%) 11 (1.2%) 19 (1.7%) 0.78 (0.33, 1.83) 
1 Adjusted for age and with random effects for enrolment month. District of residency excluded due to challenges with convergence of the statistical model 
2 Water/sanitation, Assets and Maternal education 
 
  
  
Table 2: Association between demographic/clinical characteristics and prolonged or persistent diarrhoea (ProPD) based on 165 cases of ProPD 
and 967 cases with acute diarrhoea (AD) given as ORs with 95% confidence intervals (95%CI)1  
 AD 
 
ProPD 
 
Adjusted OR2 
(95% CI) 
Number of children 967 165  
Female sex, n (%) 422 (44%) 68 (41%) 0.81 (0.50, 1.30) 
Age, months, mean (sd) 16.9 (±11.8) 15.0 (±11.4) 0.99 (0.97, 1.02) 
Mid-upper arm circumference ≤125 mm for >6 months, n (%) 78 (9%) 26 (19%) 2.10 (1.05, 4.22) 
Stunting, n (%) 184 (19%) 45 (27%) 1.99 (1.16, 3.42) 
Exclusive breastfeeding, <6 months, n (%) 342 (38%) 70 (46%) 1.04 (0.64, 1.69) 
Born prematurely, n (%) 55 (6%) 9 (6%) 0.41 (0.13, 1.29) 
WAM3 index, < 0.50, n (%) 470 (50%) 68 (43%) 1.18 (0.70, 1.98) 
Rotavirus vaccinated, n (%) 915 (95%) 150 (91%) 2.68 (0.50, 14.37) 
History of vomiting, n (%) 563 (58%) 80 (48%) 0.63 (0.39, 1.02) 
History of fever, n (%) 425 (44%) 67 (41%) 0.92 (0.56, 1.49) 
Fever, measured, n (%) 144 (15%) 13 (8%) 0.45 (0.20, 1.04) 
Antibiotic use in previous week, n (%) 78 (8%) 38 (24%) 1.45 (0.72, 2.91) 
Zinc use in previous week, n (%) 57 (6%) 41 (25%) 3.49 (1.71, 7.12) 
Primary reason for visit not diarrhoea, n (%) 117 (14%) 18 (13%) 1.04 (0.50, 2.15) 
Health facility visit in previous month, n (%) 331 (34%) 74 (45%) 1.59 (0.98, 2.58) 
Admission to health facility, n (%) 89 (9%) 17 (10%) 0.67 (0.29, 1.53) 
Previous treatment for malnutrition, n (%) 14 (1%) 5 (3%) 0.96 (0.18, 5.21) 
Moderate to severe diarrhoea, n (%) 158 (19%) 38 (26%) 1.13 (0.59, 2.15) 
Stool characteristics    
Stool frequency per day, ≥ 5, n (%) 374 (39%) 82 (50%) 1.23 (0.77, 1.99) 
Watery stool, n (%) 183 (19%) 32 (20%) 0.76 (0.42, 1.39) 
1 Five cases had missing information on duration of diarrhoea 
2 Adjusted for age and with random effects for district of residency and enrolment month 
3 Water/sanitation, Assets and Maternal education 
 
  
 
Table 3: Existing general syndromic management recommendations by duration of diarrhoea and divided 
into degrees of acute malnutrition, highlighting the present knowledge gaps 
 Acute diarrhoea Prolonged diarrhoea Persistent diarrhoea  
No acute 
malnutrition 
Zinc supplementation 
and rehydration when 
needed (1) 
No specific 
recommendations, 
currently treated as acute 
diarrhoea.  
 
 
Clinical trials needed 
 
Lactose reduced nutritional 
therapy and antibiotics and 
rehydration when needed 
(12) 
 
A simpler intervention and 
clinical trials needed  
Moderate acute 
malnutrition 
(MAM) 
No specific 
recommendations 
besides nutritional 
supplementation (10) 
and rehydration for 
acute diarrhoea (1).  
 
 
Clinical trials needed 
No specific 
recommendations besides 
nutritional 
supplementation (10) and 
rehydration as for acute 
diarrhoea (1).  
 
 
Clinical trials needed 
No specific 
recommendations besides 
nutritional supplementation 
(10) and/or lactose reduced 
nutritional therapy and 
antibiotics and rehydration 
when needed (12). 
 
Clinical trials needed 
 
Severe acute 
malnutrition  
(SAM) 
Nutritional therapy, 
antibiotics, rehydration 
when needed (9).  
 
Clinical trials needed 
Nutritional therapy, 
antibiotics, rehydration 
when needed (9). 
 
Clinical trials needed 
Nutritional therapy, 
antibiotics, rehydration when 
needed (9). 
 
Clinical trials needed 
 
 
 
 
 
